US 10106796
Compound and method for treating myotonic dystrophy
granted A61PA61P21/00
Quick answer
US patent 10106796 (Compound and method for treating myotonic dystrophy) held by Sarepta Therapeutics, Inc. expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P21/00